WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027431) METHOD OF TREATING ARTHRITIS WITH HUMAN PARVOVIRUS B19 ANTIGENS OR ANTIBODIES AGAINST SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027431    International Application No.:    PCT/US1999/026150
Publication Date: 18.05.2000 International Filing Date: 04.11.1999
Chapter 2 Demand Filed:    08.06.2000    
IPC:
A61K 39/00 (2006.01), A61K 39/23 (2006.01), C07K 14/015 (2006.01), C07K 16/08 (2006.01)
Applicants: MED IMMUNE, INC. [US/US]; 35 West Watkins Mill Road Gaithersburg, MD 20878 (US)
Inventors: BOSTIC, Jennifer, R.; (US).
KOENIG, Scott; (US)
Agent: LILLIE, Raymond; Carella, Byrne, Bain, Gilfillan, Cecchi, Stewart & Olstein 6 Becker Farm Road Roseland, NJ 07068 (US)
Priority Data:
60/107,848 10.11.1998 US
Title (EN) METHOD OF TREATING ARTHRITIS WITH HUMAN PARVOVIRUS B19 ANTIGENS OR ANTIBODIES AGAINST SAME
(FR) PROCEDE RELATIF AU TRAITEMENT DE L'ARTHRITE PAR LE BIAIS D'ANTIGENES OU D'ANTICORPS VIS-A-VIS DU PARVOVIRUS B19
Abstract: front page image
(EN)This application relates to a method for preventing or treating arthritis, in particular, rheumatoid arthritis with a human parvovirus B19 polypeptide as an immunoactive vaccine or with antibodies against such polypeptide to provide passive parvovirus B19 immunity treatment of such arthritis. In one aspect the application relates to a method which causes a cellular response to such vaccine, in particular a CTL response.
(FR)L'invention concerne un procédé relatif à la prévention ou au traitement de l'arthrite, en particulier la polyarthrite rhumatoïde, par le biais d'un polypeptide de parvovirus B19 humain tenant lieu de vaccin immunoactif ou par le biais d'anticorps vis-à-vis de ce polypeptide, de manière à assurer contre le parvovirus B19 un traitement d'immunité passive adapté à l'arthrite considérée. Selon un aspect, l'invention concerne un procédé déclenchant une réponse cellulaire au vaccin en question, en particulier une réponse CTL.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)